Fluoroquinolones Get New Safety Labeling, But Not A REMS
This article was originally published in The Pink Sheet Daily
Executive Summary
Risk of disabling, potentially permanent serious side effects that can occur together will be added to Cipro, Levaquin labels along with limitation against use for some self-limiting conditions unless there are no alternative treatments.